Exagen Inc. (NASDAQ: XGN) Stock Information | RedChip

Exagen Inc. (NASDAQ: XGN)


$5.0000
-0.0200 ( -1.96% ) 65.8K

Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.

Market Data


Open


$5.0000

Previous close


$5.0200

Volume


65.8K

Market cap


$88.54M

Day range


$4.7480 - $5.2200

52 week range


$1.3003 - $6.2200

SEC Filings


Form Type Description Pages Date
8-k/a 8K-related 13 Aug 02, 2024
4 Insider transactions 1 Jun 14, 2024
3 Insider transactions 2 Jun 14, 2024
4 Insider transactions 1 Jun 12, 2024
4 Insider transactions 1 Jun 12, 2024
4 Insider transactions 1 Jun 12, 2024
4 Insider transactions 1 Jun 12, 2024
8-k 8K-related 13 Jun 11, 2024
4 Insider transactions 1 May 16, 2024
10-q Quarterly Reports 61 May 13, 2024

Latest News